Verbatim response from ChatGPT
Short answer: many mainstream telehealth primary‑care platforms and several specialized weight‑loss telehealth clinics will prescribe semaglutide (Ozempic) when it’s medically appropriate. Availability and whether they prescribe the brand Ozempic versus another semaglutide product (Wegovy, generic/other formulations) vary by company, state law, clinical judgment, and current supply.
Examples to check (why they’re listed):
- Teladoc — large national telehealth provider that manages chronic conditions; clinicians can prescribe diabetes meds after virtual evaluation.
- Amwell — national telemedicine platform offering primary‑care and specialty visits; may prescribe GLP‑1s for diabetes/weight loss as appropriate.
- PlushCare — ongoing primary care and chronic disease management via telehealth; commonly manages diabetes meds including GLP‑1 prescriptions.
- One Medical (now part of Amazon) — membership primary care with virtual visits; primary care physicians/endocrinology can prescribe semaglutide when indicated.
- Doctor On Demand / Included Health — virtual primary care and specialty care; may prescribe diabetes and weight‑management meds after assessment.
- Ro (Roman) — operates dedicated weight‑management telehealth programs and has prescribed GLP‑1 drugs through virtual consults.
- Hims & Hers (Hims) — offers online weight‑loss/GLP‑1 programs and telehealth prescriptions subject to clinical review.
- Calibrate — a digital metabolic‑health program built around weight loss and metabolic management that may include GLP‑1 therapy as part of its program.
- GoodRx Care / HeyDoctor — offers telehealth visits and prescriptions and has been a route for GLP‑1/semaglutide prescriptions for some patients.
- MDLive — national telehealth company providing primary care and chronic care visits that can result in prescriptions when appropriate.
Important points:
- Clinicians will only prescribe if it’s medically appropriate (type 2 diabetes, obesity, contraindications, pregnancy, pancreatitis history, cancer risks, etc. are all considered).
- Many providers prefer to prescribe the brand that matches the FDA‑indicated use (Ozempic is labeled for type 2 diabetes; Wegovy is the semaglutide brand FDA‑approved for weight loss). Some clinicians avoid off‑label Ozempic prescribing for weight loss.
- Supply shortages and payer/insurance coverage can affect availability.
- Rules vary by state and by platform; some platforms don’t prescribe certain meds or require in‑person visits for initiation.
If you want, tell me your state and whether you’re seeking Ozempic for diabetes vs weight loss and I can check which of these providers explicitly advertises semaglutide prescribing in your area and how to start a visit.